Phosphorus supported carbene transition metal complexes

ABSTRACT

The present invention relates to novel complexes of (transition) metals containing ligands having phosphorus centers supporting a carbene atom or heteroalkane radical bonded to the (transition) metal.

FIELD OF THE INVENTION

[0001] The present invention relates to novel complexes of metals preferably transition metal and to processes for producing such complexes. The complexes contain at least one phosphorus center, and a carbon atom or an alkyl radical bonded to the metal to form a carbene or metal heteroatom alkenyl bond.

BACKGROUND OF THE INVENTION

[0002] Currently there is increasing interest in complexes of transition metals having a novel structure. Potentially such compounds could have significant use in a number of applications such as chemical processing, herbicides, pesticides and possibly medical fields.

[0003] Recently there has been significant interest in the catalyst of Brookhart et al which may activate later transition metals in a polymerization process. Such complexes are disclosed, for example, in World patent application 96/23010 jointly in the names of The University of Carolina at Chapel Hill and E.I. DuPont published Aug. 1, 1996. The Brookhart et al patent application does not teach the complexes of the present invention.

[0004] The recent paper (Chem. Comm (1998) p. 849) by the coworkers of Gibson at Imperial College UK (and BP) teach complexes having a novel structure that is dissimilar to the complexes of the present invention. It is postulated the complexes of Gibson will have utility in the polymerization of certain monomers such as alpha olefins.

[0005] There has been a great deal of work recently by both Exxon in the field of metallocene chemistry and by the Dow Chemical Company in single site constrained geometry complexes. As far as applicant has been able to determine none of the chemistry proposed by either Exxon or Dow contain a carbene atom or a constrained alkyl carbon bonded to a transition metal.

[0006] There are several patents relating to amidinato complexes of transition metals which are suitable for the polymerization of various olefins. U.S. Pat. No. 5,502,128 issued Mar. 26, 1996, assigned to the University of Massachusetts, teaches such complexes may be used to polymerize vinyl aromatic monomers; and U.S. Pat. No. 5,707,913 issued Jan. 13,1998, assigned to BASF, teaches such compounds may be used polymerize olefins. Neither of these patents disclose complexes of the structure of the present invention.

[0007] U.S. Pat. No. 5,557,023 issued September, 1996, teaches the use of some complexes of transition metals to oligomerize lower alpha olefins such as ethylene to higher olefins such as hexene and the like. The complexes of the patent do not contain a carbene atom or substituted carbon bonded to the transition metal.

[0008] Applicant has been unable to identify any prior art disclosing the complexes of the present invention. In short the complexes of the present invention represent a novel chemistry having potential applications in many fields.

SUMMARY OF THE INVENTION

[0009] The present invention provides a complex having the formula:

[0010] wherein M is a metal atom; R¹, R², R³ and R⁴ are independently selected from the group consisting of a hydrogen atom, a saturated or unsaturated straight chained, branched or cyclic hydrocarbyl radical which is unsubstituted or substituted by one or more substituents selected from the group consisting of a halogen atom and a C₁₋₆, most preferably a C₁₋₄ alkyl radical; R⁷ and R⁸ are independently selected from the group consisting of a hydrogen atom, a halogen atom, an amide —NR¹R², imide ═NR¹, alkoxide or aryl oxide group —OR¹, and an —OSi(R¹)₃ group where R¹ and R² are defined above, and a saturated or unsaturated straight chained, branched or cyclic hydrocarbyl radical which are unsubstituted or substituted by a halogen atom or a C₁₋₆ alkyl radical or a Lewis base (neutral coordinating ligands) which may contain a donor heteroatom including but not limited to ethers, tertiary amines, tertiary phosphines and cyclic amines; and each R⁵ is independently selected from the group consisting of radicals selected from the group consisting of saturated and unsaturated straight chained, branched and cyclic hydrocarbyl radicals, preferably C₁₋₁₅ saturated or unsaturated straight chained, branched or cyclic hydrocarbyl radicals most preferably C₁₋₈ straight or branched alkyl radicals and C₆₋₁₂ cyclic aliphatic or aromatic radical; radicals of the formula Si(R⁶)₃ wherein each R⁶ is independently selected from the group consisting of saturated or unsaturated straight chained, branched or cyclic hydrocarbyl radicals, preferably C₁₋₁₀ saturated or unsaturated straight chained, branched or cyclic hydrocarbyl radicals; and radicals of the formula III:

[0011] wherein R⁹, R¹⁰, R¹¹ and R¹² are independently selected from the group consisting of a hydrogen atom, a fluorine atom, a NO₂ radical, a C₁₋₆ alkyl radical, and a C₈₋₁₂ aryl radical and E is an endocyclic nitrogen atom or a C—CN group.

[0012] The present invention provides a complex dilithium salt of the formula II:

[0013] wherein R¹, R², R³ and R⁴ are independently selected from the group consisting of a hydrogen atom, a saturated or unsaturated straight chained, branched or cyclic hydrocarbyl radical which is unsubstituted or substituted by one or more substituents selected from the group consisting of a halogen atom and a C₁₋₆, most preferably a C₁₋₄ alkyl radical; and each R⁵ is independently selected from the group consisting of radicals selected from the group consisting of a saturated or unsaturated straight chained, branched or cyclic hydrocarbyl radicals preferably C₁₋₁₅ saturated or unsaturated straight chained, branched or cyclic hydrocarbyl radicals, most preferably C₁₋₈ straight or branched alkyl radicals and C₆₋₁₂ cyclic aliphatic or aromatic radicals; radicals of the formula Si(R⁶)₃ wherein each R⁶ is independently selected from tho group consisting of saturated or unsaturated straight chained, branched or cyclic hydrocarbyl radicals, preferably C₁₋₁₀ saturated or unsaturated straight chained, branched or cyclic hydrocarbyl radicals; radicals of the formula III:

[0014] wherein R⁹, R¹⁰, R¹¹ and R¹² are independently selected from the group consisting of a hydrogen atom, a fluorine atom, a NO₂ radical, a C₁₋₆ alkyl radical, and a C₈₋₁₂ aryl radical and E is an endocyclic nitrogen atom or a C—CN group.

[0015] The present invention also provides processes for the production of the above complexes comprising either:

[0016] (A) reacting a compound of the formula I:

[0017]  wherein R¹, R², R³, R⁴ and R⁵ are as defined above, with a compound of the formula M(X)_(s)(Y)_(t)(L)_(n) wherein M is as defined above, X is independently selected from a group consisting of an alkyl radical, preferably having from 1 to 10 carbon atoms which is unsubstituted or substituted by a C₁₋₄ alkyl radical or a C₆₋₁₀ aryl (e.g. benzyl) radical, a silylated amido or imido complex —N(Si(R⁶)₃)₂ or ═N(Si(R⁶)₃ where R⁶ is defined above, or imido ═NR radicals where R is a C₁₋₁₀ alkyl or a C₆₋₁₀ aryl radical, Y is selected from the group consisting of a halogen atom, an alkoxy radical preferably having from 1 to 10 carbon atoms and aryloxy radicals preferably having from 6 to 10 carbon atoms, and the sum of s and t equal the valence of the transition metal M and provided that at least two of the X and Y groups can be eliminated from the molecule, L is a Lewis base as defined above and n is from 0 to 3; in a C₅₋₁₂ hydrocarbyl solvent or a C₂₋₁₀ ether solvent at a temperature from 20° C. to 150° C.; or

[0018] (B) reacting a compound of the formula II:

[0019]  wherein R¹, R², R³, R⁴ and R⁵ are as defined above, with a compound of the formula M(X)_(t)(Y)_(s)(L)_(n) wherein M, L, s, t and n are as defined above, X and Y are independently selected from a group consisting of an alkyl, preferably having from 1 to 10 carbon atoms which is unsubstituted or substituted by a C₁₋₄ alkyl radical or a C₆₋₁₀ aryl (e.g. benzyl) radical, a silylated amido or imido complex —N(Si(R⁶)₃)₂ or ═N(Si(R⁶)₃ where R⁶ is defined above, or imido ═NR radicals where R is a C₁₋₁₀ alkyl or a C₆₋₁₀ aryl radical, a halogen atom, an alkoxy radical preferably having from 1 to 10 carbon atoms and aryloxy radical preferably having from 6 to 10 carbon atoms, and the sum of s and t equal the valence of the transition metal M and provided that at least two of the X and Y groups can be eliminated from the molecule, in a C₅₋₁₂ hydrocarbyl solvent or a C₂₋₁₀ ether solvent at a temperature from 20° C. to 150° C.

[0020] The present invention further provides a process comprising reacting a complex of the formula:

[0021] wherein R¹, R², R³, R⁴ and R⁵ are as defined above, and at least one of R⁷ and R⁸ are halogen atoms and the other may be a Lewis base as defined above, with a Grignard reagent or an alkylating or alkoxylating agent.

DETAILED DESCRIPTION

[0022] In the complexes of the present invention the metal may be any transition metal. It may be an early transition metal such as Y, Ti, V, Zr, Hf or Cr or it may be a later transition metal such as Ni, Pd, Pt, group 11 or 12, a post transition metal (Zn) or a lanthanide group metal, preferably Sm. Preferably the transition metal will be selected from group 3 through 10 (formerly group IIIB through VIII) of the periodic table.

[0023] The transition metal precursor M(X)_(s)(Y)_(t)(L)_(n) must contain at least two X or Y substituents which are eliminated in reaction with the compounds of formula I or formula II.

[0024] In accordance with the present invention R¹, R², R³ and R⁴ may be independently selected from the group consisting of a hydrogen atom, a saturated or unsaturated straight chained, branched or cyclic hydrocarbyl radical which is unsubstituted or substituted by one or more substituents selected from the group consisting of a halogen atom and a C₁₋₆, most preferably a C₁₋₄ alkyl radical. Preferably, the hydrocarbyl radicals may be selected from the group consisting of a C₁₋₁₀, preferably C₁₋₈, most preferably C₁₋₆ straight chained, branched or cyclic alkyl radicals which radicals may be unsubstituted or further substituted, preferably by not more than three substituents selected from the group consisting of C₁₋₄ alkyl radicals or a halogen atom, preferably either F or Cl. Additionally, substituents R¹, R², R³ and R⁴ may be independently selected from the group consisting of C₅₋₁₄ aromatic radicals which radicals are unsubstituted or substituted by up to n−1, wherein n is the number of carbon atoms in the aromatic radical, substituents selected from the group consisting of a halogen atom, preferably F or Cl, a C₁₋₆, most preferably a C₁₋₄ alkyl radical or an amido radical which is unsubstituted or substituted by up to two C₁₋₆, preferably C₁₄ alkyl radicals.

[0025] The substituents R¹, R², R³ and R⁴ may be selected from the group consisting of a hydrogen atom, a fluorine atom, a chlorine atom, a methyl radical, an ethyl radical, a propyl radical, a butyl radical, a tertiary butyl radical, and a phenyl radical.

[0026] In some embodiments of the present invention R¹ and R² may be the same. In a further embodiment R³ and R⁴ may be the same. In a further embodiment of the present invention all of R¹, R², R³ and R⁴ may be the same.

[0027] In the present invention R⁷ and R⁸ may be independently selected from the group consisting of a hydrogen atom, a halogen atom, an amide radical —NR¹R², imide ═NR¹, alkoxide or aryl oxide group —OR¹, and an —O—Si(R¹)₃ group where R¹ and R² are defined above; and a saturated or unsaturated straight chained, branched or cyclic hydrocarbyl radical which are unsubstituted or substituted by a halogen atom, a C₁₋₆ alkyl radical or a Lewis base (neutral coordinating ligands) which may contain a donor heteroatom including but not limited to ethers, tertiary amines, tertiary phosphines and cyclic amines. The hydrocarbyl radical may be a straight chained or branched C₁₋₁₀ alkyl radical which may be unsubstituted or substituted by a F or Cl atom or up to three C₁₋₆, preferably C₁₋₄ alkyl radicals. The hydrocarbyl radical may be selected from the group consisting of C₅₋₁₄ aromatic radicals which radicals are unsubstituted or substituted by up to n−1, wherein n is the number of carbon atoms in the aromatic radical, substituents selected from the group consisting of a halogen atom, preferably F or Cl, a C₁₋₆, most preferably a C₁₋₄ alkyl radical or an amido radical which is unsubstituted or substituted by up to two C₁₋₆, preferably C₁₋₄ alkyl radicals. Some suitable Lewis bases (neutral coordinating ligands) comprise one or more donor heteroatoms including but not limited to C₁₋₆ alkyl ethers, C₄₋₈ cyclic ethers, C₁₋₆ tertiary amines and cyclic nitrogen aromatics from 4 to 8 carbon atoms such as pyridine or tertiary C₁₋₁₀ phosphines. In one embodiment of the invention at least one of R⁷ and R⁸ may be C₅₋₁₃ ligand containing a 5-membered carbon ring having delocalized bonding within the ring and typically being bound to the metal through covalent η⁵-bonds such as cyclopentadienyl, indenyl or fluorenyl ligands which are unsubstituted or up to fully substituted by a halogen atom, preferably chlorine or fluorine, a C₁₋₄ alkyl radical or an amido radical which is unsubstituted or substituted by up to two C₁₋₄ alkyl radicals.

[0028] In accordance with the present invention each R⁵ is independently selected from the group consisting of radicals of a saturated or unsaturated straight chained, branched or cyclic hydrocarbyl radical, preferably C₁₋₁₅ saturated or unsaturated straight chained, branched or cyclic hydrocarbyl radicals, most preferably a C₁₋₈ straight or branched alkyl radical and a C₆₋₁₂ cyclic aliphatic or aromatic radical; radicals of the formula Si(R⁶)₃ wherein each R⁶ is independently selected from the group consisting of saturated or unsaturated straight chained, branched or cyclic hydrocarbyl radicals, preferably C₁₋₁₀ saturated or unsaturated straight chained, branched or cyclic hydrocarbyl radicals preferably C₁₋₁₀ saturated or unsaturated straight chained, branched or cyclic hydrocarbyl radicals; radicals of the formula III:

[0029] wherein R⁹, R¹⁰, R¹¹ and R¹² are independently selected from the group consisting of a hydrogen atom, a fluorine atom, a NO₂ radical, a C₁₋₆ alkyl radical, and a C₈₋₁₂ aryl radical and E is an endocyclic nitrogen atom or a C—CN group.

[0030] Each R⁵ radical may be selected from the group consisting of radicals of the formula Si(R⁶)₃ wherein each R⁶ is independently selected from the group consisting of saturated or unsaturated straight chained, branched or cyclic hydrocarbyl radicals, preferably C₁₋₁₀ saturated or unsaturated straight chained, branched or cyclic hydrocarbyl radicals. Most preferably R is selected from C₁₋₈, preferably C₁₋₆, most preferably C₁₋₄ alkyl radicals. Suitable alkyl radicals include methyl, ethyl, propyl and butyl radicals. In a preferred embodiment of this aspect of the invention each R⁶ radical is the same.

[0031] Each R⁵ radical may be selected from the group consisting of radicals of the formula III:

[0032] wherein R⁹, R¹⁰, R¹¹ and R¹² are independently selected from the group consisting of a hydrogen atom, a fluorine atom, a NO₂ radical, a C₁₋₆ alkyl radical, and a C₈₋₁₂ aryl radical and E is an endocyclic nitrogen atom or a C—CN group. Such radicals includes the 4-cyanotetrafluorophenyl radical.

[0033] Independently each R⁵ radical may selected from the group consisting of consisting of saturated or unsaturated straight chained, branched or cyclic hydrocarbyl radicals, preferably C₁₋₁₅ saturated or unsaturated straight chained, branched or cyclic hydrocarbyl radicals most preferably a C₁₋₈ straight or branched alkyl radical and a C₆₋₁₂ cyclic aliphatic or aromatic radical. Some hydrocarbyl radicals include methyl, ethyl, butyl, phenyl and adamantyl radicals.

[0034] The compounds of the present invention may be prepared by reacting a compound of the formula I as defined above wherein R¹, R², R³, R⁴ and R⁵ are as defined above with a compound of the formula M(X)_(s)(Y)_(t)(L)_(n) wherein M is as defined above, X is independently selected from a group consisting of an alkyl radical, preferably having from 1 to 10 carbon atoms which is unsubstituted or substituted by a C₁₋₄ alkyl radical or a C₆₋₁₀ aryl (e.g. benzyl) radical, a silylated amido or imido complex —N(Si(R⁶)₃)₂ or ═N(Si(R⁶)₃)₂ where R⁶ is defined above, or imido ═NR radicals where R is a C₁₋₁₀ alkyl radical or a C₆₋₁₀ aryl radical, Y is a halogen atom, a alkoxy radical preferably having from 1 to 10 carbon atoms and aryloxy radical preferably having from 6 to 10 carbon atoms, and the sum of s and t equal the valence of the transition metal M and provided that at least two of the X and Y groups can be eliminated from the molecule, in a C₅₋₁₂ hydrocarbyl solvent or a C₂₋₁₀ ether solvent at a temperature from 20° C. to 150° C. Suitably X and Y radicals include but are not limited to bis(trimethylsilyl) amido; benzyl; and suitable Lewis bases include, but are not restricted to diethyl ether or tetrahydrofuran. L is a Lewis base (neutral coordinating ligands) which may contain a donor heteroatom including but not limited to ethers, tertiary amines, tertiary phosphines and cyclic amines. Some suitable Lewis bases (neutral coordinating ligands) comprise one or more donor heteroatoms including but not limited to C₁₋₆ alkyl ethers, C₄₋₈ cyclic ethers, C₁₋₆ tertiary amines, cyclic nitrogen aromatics from 4 to 8 carbon atoms such as pyridine, or tertiary C₁₋₁₀ phosphines, and n may range from 0 to 3. The final form of the compound may retain some of the Lewis bases components defined as L or a similar species obtained from the reaction solvent. Alternatively the compound above of the formula I may be reacted with two moles of alkyl lithium reagent to prepare the dilithio derivative of the formula {R¹R²{N(R⁵)}PC(Li)₂PR³R⁴{N(R⁵)}:

[0035] (formula II (preferably R⁵ is Si(R⁶)₃ wherein R⁶ is a C₁₋₄ alkyl radical) which in turn can be reacted with metal halide or alkyl halide precursors M(X)_(s)(Y)_(t)(L)_(n) as defined above containing at least two halogen atoms as replaceable substituents in the X and Y group.

[0036] The complexes of the present invention wherein the R⁷ and R⁸ are halogens and may be alkylated or alkoxylated by reacting with suitable alkylating agents such as LiR or RMgX or alkoxylating agent which is an alkali alkoxide (e.g. M²OR where M² is selected from the group consisting of alkali metals, preferably sodium). In the alkylating or alkoxylating agent, the alkyl or alkoxide radical is as defined in R⁷ and R⁸ above.

[0037] Some hydrocarbon solvents include C₅₋₁₂ hydrocarbons which may be unsubstituted or substituted by C₁₋₄ alkyl group, such as pentane, hexane, heptane, octane, cyclohexane, methylcyclohexane and hydrogenated naphtha. An additional solvent is Isopar E (C₈₋₁₀ aliphatic solvent, Exxon Chemical Co.). The solvent may be aromatic such as benzene, toluene or xylene. The solvent may also be a simple or branched ether in which the alkyl radicals may contain from 1 to 10 carbon atoms or a polyether thereof such as diethyl ether and diglyme. The product is recovered using conventional procedures illustrated in the examples. The reaction may be carried out from room temperature (20° C.) to about 150° C.

[0038] The present invention will be illustrated by the following non-limiting examples in which, unless otherwise specified, part means parts by weight (e.g. grams) and per cent means weight per cent.

[0039] Synthesis of Ligands and Metal Carbene Complexes

[0040] General Experimental Conditions

[0041] All experimental manipulations were performed under rigorously anaerobic conditions using Schlenk techniques or an argon-filled glovebox with an efficient recirculator. Solvents were dried and distilled under argon prior to use. Hexane and toluene were distilled from Na—K and Na respectively. NMR solvents benzene-d₆ and toluene-d₈ were freshly vacuum transferred from Na—K. Commercial (Aldrich) supplies of dppm, Me₃SiN₃, ZrCl₄ and HfCl₄ were used as obtained. NMR spectra were recorded using Bruker® WH-200, 300 and 400 spectrometers with reference to the deuterium signal of the solvent employed. The ¹H NMR chemical shifts are reported in ppm from external Me₄Si and the ³¹p NMR spectra are reported in ppm from external 85% H₃PO₄. Positive values reflect shifts downfield. Infrared spectra were recorded on a Nicolet® 7199 infrared spectrometer.

[0042] Preparation of Ligands

[0043] Preparation of CH₂[Cy₂P═NSiMe₃]₂

[0044] To a solution of dcpm, {Cy₂P}₂CH₂, (literature preparation: Fryzuk, M. D.; McConville, D. H.; Rettig, S. J. J. Organomet. Chem. 1993, 445, 245-256.}(3.97 g, 9.72 mmol) in 60 mL of toluene was added trimethylsilyl azide (6 mL, 45.79 mmol) with stirring. The solution was heated to reflux at 110° C. for 48 hours. Solvent was evaporated under vacuum to obtain microcrystalline solid which was washed twice with hexane and dried (Yield: 4.85 g, 85.6%). IR (Nujol mull): 2666 w, 2653 w, 1449 s, 1376 m, 1348m, 1302s, 1264 s, 1244 s, 1233 s, 1209 m, 1173 m, 1154 m, 1119 w, 1078 w, 1045 w, 1028 w, 1004 m, 913 w, 896 m, 852 s, 827 s, 787 s, 776 s, 751 s, 675 m, 663 m, 633 m, 571 w, 526 m. ¹H NMR (C₆D₆): δ1.95 (b. t, 4 H, CH—Cy methine), 1.7 (m, CH₂—Cy methylene), 1.62 (d, ²J_(PH)=12.2 Hz, 2 H, PCH₂P methylene), 1.40-1.05 (m, CH₂—Cy methylene), 0.38 (s, 18 H, CH₃Si methyl). ¹³C{¹H} NMR (C₆D₆): δ39.5 (m, 4 C, CH—Cy, methine), 27.1 (s, 4 C, para Cy), 27.0 (s, 8 C, ortho Cy), 26.8 (s, 4 C, meta Cy), 26.5 (s, 4 C, meta Cy), 21.6 (t, ¹J_(PC)=61.6 Hz, 1 C, PCH₂P methylene), 5.3 (s, 6 C, CH₃Si). ¹³{¹H, ³¹P} NMR (C₆D₆): δ39.5 (s, 4 C, CH—Cy, methine), 27.1 (s, 4 C, para Cy), 27.0 (s, 8 C, ortho Cy), 26.8 (s, 4 C, meta Cy), 26.5 (s, 4 C, meta Cy), 21.6 (s, 1 C, PCH₂P methylene), 5.3 (s, 6 C, CH₃Si). ³¹P{¹H} NMR (C₆D₆): δ14.6 (2 P). Analysis calculated for C₃₁H₆₄N₂P₂Si₂: C, 63.87; H, 11.06; N, 4.81. Found: C, 63.55; H, 11.22; N, 4.63.

[0045] Preparation of CH₂[Ph₂P═NSiMe₃]₂

[0046] As described in the literature {Appel, R.; Ruppert, I. Z. anorg. allg. Chem. 1974, 406, 131-144.}.

[0047] Preparation of CH₂(Ph₂P═NAd)₂

[0048] Adamantyl azide (1.66 g, 9.37 mmol) was added to a solution of bis(diphenylphosphino)methane (dppm) (1.80 g, 4.68 mmol) in 60 mL of toluene. The mixture was heated to reflux at 110° C. for 2 days. The solution was then cooled to room temperature, concentrated to about 20 mL, and maintained at −15° C. to yield, after about 12 hours, a microcrystalline solid which was filtered and dried (Yield: 2.56 g, 80%). ¹H NMR (toluene-d₈): δ7.87 (b. s, 8 H, ortho-Ph), 7.05 (b. s, 12 H, meta and para-Ph), 3.48 (b. t, 2 H, CH₂), 1.99 (b.s, 3 H, CH—Ad), 1.93 (b. s, 6 H, CH₂—Ad), 1.59 (b. s, 6 H, CH₂—Ad). ³¹P{¹H} NMR (toluene-d₈): δ−15.4 (s). Analysis calculated for C₄₅H₅₂N₂P₂: C, 79.15; H, 7.68; N, 4.10. Found: C, 78.58; H, 7.93; N, 4.03.

[0049] Preparation of Me₃Si═NPPh₂CH₂Ph₂P═NC₆F4-p-CN

[0050] To a solution of bis(diphenylphosphino)methane (dppm) (11.17 g, 20 mmol) in dichloromethane a solution of pentafluorobenzonitrile (4.05 g, 21 mmol) in dichloromethane (35 mL) was added at room temperature. Immediately the solution turned yellow and after stirring for 12 hours became orange. The solvent was completely removed in vacuo leaving the slightly orange colored crude product which was recrystallized from acetonitrile giving the pure ligand (Yield: 10.28 g, 78%; white cubic crystals; mp 198-200° C.). Analysis calculated for C₃₅H₃₁F₄N₃P₂Si: C, 63.77; H, 4.69; N, 6.36. Found: C, 63.01; H, 4.70; N, 6.46. MS (EI, m/z): 659 (M⁺). ¹H NMR (CD₂Cl₂): phenyl rings δ7.80 to 7.74 ppm, 7.57 to 7.29 ppm (m, 20H); PCH₂ P methylene, δ3.75 ppm (‘t’, 2H , ²J_(HP) 13.39 Hz); Me₃ Si methyl δ−0.29 ppm (s, 9H). ¹⁹F{¹H} NMR (CDCl₂): ortho δ−140.17 ppm (m, 2F); meta δ−153.32 ppm (m, 2F). ²⁹Si{¹H} NMR (CDCl₂), δ−10.59 ppm (d, ²JSiP 20.49 Hz).

[0051] Preparation of {Li₂C{Ph₂P═NSiMe₃}₂}

[0052] Colorless crystalline bis(diphenylphosphinomethyltrimethysilylimino) methane H₂C{Ph₂P═NSiMe₃}₂ (1.0 g, 1.79 mmol) was dissolved in 20 mL of toluene. To this toluene solution, PhLi (0.30 g, 3.59 mmol) was added with stirring. The reaction mixture was stirred at room temperature for 3 days. Approximately 100 mg of colorless solid was removed by filtration. The clear solution was reduced to one-half volume and allowed to stand at room temperature for 48 hours whereupon colorless crystals deposited. (Yield: 0.62 g, 60.7%). IR (Nujol mull): 1434 m, 1244 s, 1190 s, 1174 m, 1101 s, 1067 s, 852 s, 832 s, 764 m, 747 m, 725 m, 709 m, 696 s, 675 w, 663 w, 646 s, 618 w, 606 w, 539 s, 512 m. ¹H NMR (C₆D₆): δ7.53-7.49 (m, phenyl), 7.04-6.93 (m, phenyl), 0.04 (s, CH₃Si methyl). ¹³C{¹H} NMR (C₆D₆): δ139.0 (m, 4 C, ipso phenyl), 131.0 (t, ²J_(PC)=4.5 Hz, 8 C, ortho phenyl), 129.0 (s, 4 C, para phenyl), 127.8 (s, 8 C, meta phenyl), 4.4 (s, 6 C, CH₃Si). ³¹P{¹H} NMR (C₆D₆): δ13.7 (2 P). Analysis calculated for C₃₁H₃₈Li₂N₂P₂Si₂: C, 65.25; H, 6.71; N, 4.91. Found: C, 65.27; H, 6.69; N, 4.60.

[0053] Preparation of Metal Carbene and Related Derivatives

[0054] Preparation of [ZrCl₂{C(Cy₂P═NSiMe₃)₂}]

[0055] [ZrCl₂{N(SiMe₃)₂}₂] (0.5 g, 1.04 mmol) {literature preparation: Andersen, R. A. Inorg. Chem. 1979, 18, 1724-1725} was dissolved in 15 mL of toluene by stirring. Solid bisimine ligand, CH₂(Cy₂P═NSiMe₃)₂ (0.604 g, 1.04 mmol) was added to the solution which was then heated to reflux at 130° C. for five days. The pale yellow solution was concentrated to about 10 mL and left at room temperature for 24 hours whereupon pale yellow crystals formed which were isolated by filtration (0.42 g). The mother liquor was concentrated 5 mL hexane added and the total mixture was cooled to −15° C. for 24 hours which yielded a second crop of product (0.15 g). (Yield: 0.57 g, 75.2%). IR (Nujol mull): 1447 s, 1403 w, 1377 m, 1356 w, 1321 s, 1258 s, 1246 s, 1200 w, 1192 m, 1176 m, 1167 w, 1111 m, 1049 b.s, 998 m, 915 w, 887 m, 837 s, 779 m, 769 s, 753 m, 746 s, 679 m, 651 s, 634 m, 609 s, 551 s, 509 w, 495 m, 484 w, 465 w. ¹H NMR (C₆D₆): δ2.1-1.1 (b. m, 40 H, CH₂—Cy methylene), 1.76 (m, 4 H, CH—Cy methine) (as assigned from a ¹H—¹³C HMQC expt.), 0.51 (s, 18 H, CH₃Si methyl). ¹³C {¹H} NMR (C₆D₆): δ86.9 (t, ¹J_(PC)=156.0 Hz, 1 C PCP carbene), 40.3 (m, 4 C, CH—Cy, methine), 26.8 (m, 8 C, ortho Cy), 26.6 (s, 4 C, para Cy), 26.3 (s, 4 C, meta Cy), 26.1 (s, 4 C, meta Cy), 3.4 (s, 6 C, CH₃Si). ¹³C {¹H, ³¹P} NMR (C₆D₆): δ86.9 (s, 1 C, PCP carbene), 40.3 (s, 4 C, CH—Cy, methine), 26.9 (s, 4 C, ortho Cy), 26.8 (s, 4 C, ortho Cy), 26.6 (s, 4 C, para Cy), 26.3 (s, 4 C, meta Cy), 26.1 (s, 4 C, meta Cy), 3.4 (s, 6 C, CH₃Si). ³¹P{¹H} NMR (C₆D₆): δ35.5 (2 P). Analysis calculated for C₃₁H₆₂Cl₂N₂P₂Si₂Zr: C, 50.11; H, 8.41; N, 3.77. Found: C, 49.97; H, 8.68; 3.63.

[0056] Preparation of [ZrCl₂{C(Ph₂P═NSiMe₃)₂}]

[0057] [ZrCl₂{N(SiMe₃)₂}₂] {literature preparation: Andersen, R. A. Inorg. Chem. 1979, 18, 1724-1725} (1.0 g, 2.07 mmol) was dissolved in 20 mL of toluene by stirring. The bisimine ligand, CH₂(Ph₂P═NSiMe₃)₂, (1.16 g, 2.08 mmol) was added as a solid to the solution which was then heated to reflux at 130° C. for 24 hours. The resultant pale yellow solution was concentrated to nearly 5 mL and mixed with 5 mL of hexane. Upon cooling overnight, a pale yellow crystalline solid was obtained which was isolated by filtration (Yield: 1.05 g, 70.5%). IR (Nujol mull): 1653 w, 1480 w, 1462 m, 1436 s, 1378 w, 1304 s, 1251 s, 1179 w, 1156 w, 1112 s, 1061 s, 1042 s, 1026 m, 999 w, 842 s, 785 m, 771 w, 753 w, 747 w, 737 w, 714 s, 695 s, 652 s, 631 m, 613 s, 571 m, 522 s. ¹H NMR (C₆D₆): δ7.6 (m, phenyl), 6.98 (m, phenyl), 6.92 (m, phenyl), 6.90 (m, phenyl), 0.25 (s, 18 H, CH₃Si methyl). ¹³C {¹H} NMR (C₆D₆): δ134.2 (m, 4 C, ipso phenyl), 131.5 (t, ²J_(PC)=6.0 Hz, 8 C, ortho phenyl), 131.2 (s, 4 C, para phenyl), 128.5 (t, ³J_(PC)=6.2 Hz, 8 C, meta phenyl), 101.7 (t, ¹J_(PC)=146 Hz, 1 C, PCP carbene), 2.6 (s, 6 C, CH₃Si). ¹³C {¹H, ³¹P} NMR (C₆D₆): δ134.2 (s, 4 C, ipso phenyl), 131.5 (s, 8 C, ortho phenyl), 131.2 (s, 4 C, para phenyl), 128.5 (s, 8 C, meta phenyl), 101.7 (s, 1 C, PCP carbene), 2.6 (s, 6 C, CH₃Si). ³¹P{¹H} NMR (C₆D₆): δ15.7 (2 P). Analysis calculated for C₃₁H₃₈Cl₂N₂P₂Si₂Zr: C, 51.79; H, 5.33; N, 3.90. Found: C, 51.41; H, 5.78; N, 3.80.

[0058] Preparation of ZrCl₂{C(Ph₂P═NSiMe₃)₂}Method B

[0059] To a suspension of ZrCl₄(THF)₂ (0.13 g, 0.35 mmol) in diethyl ether (5 mL) the dilithium salt Li₂C(Ph₂P═NSiMe₃)₂ 3 (0.20 g, 0.35 mmol) was added with stirring at room temperature. The mixture was stirred at room temperature for 2 days. Diethyl ether was removed and the resultant solid product was extracted with 5 mL of toluene and filtered to remove LiCl. The toluene solution was then concentrated to half the initial volume and the solution cooled to −15° C. for 2 days whereupon colorless crystals of {ZrCl₂{C(Ph₂P═NSiMe₃)₂} precipitated (Yield: 0.16 g, 63.5%). All spectroscopic and analytical data indicated that the product was identical with the compound identified as {ZrCl₂{C(Ph₂P═NSiMe₃)₂} as described above.

[0060] Preparation of [HfCl₂{C(Cy₂P═NSiMe₃)₂}]

[0061] [HfCl₂{N(SiMe₃)₂}₂] (0.2 g, 0.35 mmol) {literature preparation: Andersen, R. A. Inorg. Chem. 1979, 18, 1724-1725} was dissolved in 10 mL of toluene and solid bisimine ligand, CH₂(Cy₂P═NSiMe₃)₂ (0.204 g, 0.35 mmol) added to the solution with stirring. The resultant colorless solution was then heated at 140° C. for seven days. The final pale yellow solution was then concentrated and cooled to −15° C. for 24 hours to yield colorless crystals which were isolated by filtration (Yield: 0.21 g, 72.1%). IR (Nujol mull): 1447 s, 1404 w, 1377 w, 1356 w, 1320 s, 1297 w, 1260 s, 1246 s, 1202 w, 1192 w, 1176 w, 1168 w, 1112 m, 1024 b.s, 915 w, 887 m, 836 b.s, 783 m, 771 s, 754 s, 747 s, 707 w, 679 m, 654 s, 635 m, 615 s, 552 s, 542 m, 495 m, 485 m, 464 w. ¹H NMR (C₆D₆): δ2.1-1.1 (b. m, 40 H, CH₂—Cy methylene & 4 H, CH—Cy methine), 0.47 (s, 18 H, CH₃Si methyl). ¹³C {¹H} NMR (C₆D₆): δ66.6 (t, ¹J_(PC)=158.0 Hz, 1 C, PCP carbene), 40.7 (m, 4 C, CH—Cy, methine), 26.8 (m, 8 C, ortho Cy), 26.6 (s, 4 C, para Cy), 26.4 (s, 4 C, meta Cy), 26.3 (s, 4 C, meta Cy), 3.5 (s, 6 C, CH₃Si). ¹³C {¹H, ³¹P} NMR (C₆D₆): δ66.6 (s, 1 C, PCP carbene), 40.7 (s, 4 C, CH—Cy, methine), 26.9 (s, 4 C, ortho Cy), 26.8 (s, 4 C, ortho Cy), 26.6 (s, 4 C, para Cy), 26.4 (s, 4 C, meta Cy), 26.3 (s, 4 C, meta Cy), 3.5 (s, 6 C, CH₃Si). ³¹P{¹H} NMR (C₆D₆): δ32.6 (2 P). Analysis calculated for C₃₁H₆₂Cl₂HfN₂P₂Si₂: C, 44.84; H, 7.53; N, 3.37. Found: C, 45.04; H, 7.98; N, 3.29.

[0062] Preparation of [HfCl₂{C(Ph₂P═NSiMe₃)₂}]

[0063] [HfCl₂{N(SiMe₃)₂}₂] (0.104 g, 0.18 mmol) {literature preparation: Andersen, R. A. Inorg. Chem. 1979, 18, 1724-1725} was dissolved in 10 mL of toluene to which was added solid bisimine ligand, CH₂(Ph₂P═NSiMe₃)₂ (0.102 g, 0.18 mmol). The solution was heated at 140° C. for 3 days, then concentrated to a small volume and layered with hexane, standing at room temperature for 2 days yielded colorless crystals which were isolated by filtration (Yield: 0.11 g, 74.8%). IR (Nujol mull): 1589 w, 1574 w, 1480 w, 1463 m, 1436 s, 1378 m, 1311 s, 1251 s, 1181 w, 1156 w, 1111 s, 1070 m, 1057 s, 1037 s, 999 m, 843 s, 787 s, 772 m, 754 m, 738 m, 716 s, 696 s, 654 s, 631 m, 622 s, 615 m, 576 m, 524 s. ¹H NMR (C₆D₆): δ7.63 (m, phenyl), 6.97 (m, phenyl), 6.91 (m, phenyl), 0.22 (s, 18 H, CH₃Si methyl). ¹³C {¹H} NMR (C₆D₆): δ134.7 (m, 4 C, ipso phenyl), 131.5 (t, ²J_(PC)=6.0 Hz, 8 C, ortho phenyl), 131.0 (s, 4 C, para phenyl), 128.5 (t, ³J_(PC)=5.6 Hz, 8 C, meta phenyl), 84.6 (t, ¹J_(PC)=145 Hz, 1 C, PCP carbene), 2.6 (s, 6 C, CH₃Si). ¹³C {¹H, ³¹P} NMR (C₆D₆): δ134.7 (s, 4 C, ipso phenyl), 131.5 (s, 8 C, ortho phenyl), 131.0 (s, 4 C, para phenyl), 128.5 (s, 8 C, meta phenyl), 84.6 (s, 1 C, PCP carbene), 2.6 (s, 6 C, CH₃Si). ³¹P{¹H} NMR (C₆D₆): δ12.2 (2 P). Analysis calculated for C₃₁H₃₈Cl₂HfN₂P₂Si₂ (0.5 toluene): C, 48.62; H, 4.97; N, 3.29. Found: C, 48.24; H, 5.21; N, 3.34.

[0064] Preparation of [Zr{C(Ph₂P═NSiMe₃)₂}(CH₂C₆H₅)₂]

[0065] [Zr(CH₂C₆H₅)₄] (1.0 g, 2.19 mmol) {literature preparation: Zucchini, U.; Albizzati, E.; Giannini, U. J. Organomet. Chem. 1971, 26, 357-372.} was added to 15 mL of toluene and stirred at room temperature. To the pale yellow brown suspension was added solid bisimine ligand, CH₂(Ph₂P═NSiMe₃)₂ (1.226 g, 2.19 mmol) at room temperature. The reaction mixture was stirred at room temperature for 2 days during which time a pale brown microcrystalline solid precipitated. The product was isolated by filtration, washed with few mL of hexane and dried (Yield: 1.34 g, 73.5%). IR (Nujol mull): 1900-1650 w, 1591 m, 1488 m, 1481 m, 1466 m, 1436 m, 1378 m, 1334 w, 1283 s, 1260 s, 1249 s, 1216 m, 1204 m, 1173 m, 1151 w, 1110 s, 1016 b.s, 971 m, 880 w, 834 b.s, 793 w, 776 s, 764 m, 743 s, 734 m, 720 s, 693 s, 656 s, 620 m, 614 m, 562 s. ¹H NMR (C₆D₆): δ7.34 (m, phenyl), 7.26 (m, phenyl), 7.24 (m, pheny l), 7.02 (m, phenyl), 6.93 (m, phenyl), 2.62 (s, 4 H, CH₂Ph methylene), 0.09 (s, 18 H, CH₃Si methyl). ¹³C {¹H} NMR (C₆D₆): δ147.7 (s, 2 C, ipso benzyl), 135.9 (m, 4 C, ipso phenyl), 131.6 (t, ²J_(PC)=6.0 Hz, 8 C, ortho phenyl), 130.5 (s, 4 C, ortho benzyl), 128.9 (s, 4 C, meta benzyl), 128.2 (t, ³J_(PC)=6.5 Hz, 8 C, meta phenyl), 126.8 (s, 4 C, para phenyl), 121.2 (s, 2 C, para benzyl), 84.7 (t, ¹J_(PC)=164 Hz, 1 C, PCP carbene), 68.8 (s, 2 C, CH₂Ph methylene), 3.6 (s, 6 C, CH₃Si). ¹³C {¹H, ³¹P} NMR (C₆D₆): δ147.7 (s, 2 C, ipso benzyl), 135.9 (s, 4 C, ipso phenyl), 131.6 (s, 8 C, ortho phenyl), 130.5 (s, 4 C, ortho benzyl), 128.9 (s, 4 C, meta benzyl), 128.2 (s, 8 C, meta phenyl), 126.8 (s, 4 C, para phenyl), 121.2 (s, 2 C, para benzyl), 84.7 (s, 1 C, PCP carbene), 68.8 (s, 2 C, CH₂Ph methylene), 3.6 (s, 6 C, CH₃Si). ³¹P{¹H} NMR (C₆D₆): δ12.4 (2 P). Analysis calculated for C₄₅H₅₂N₂P₂Si₂Zr: C, 65.10; H, 6.31; N, 3.37. Found: C, 65.65; H, 6.03; N, 3.31.

[0066] Preparation of [TiCl₂{C(Ph₂P═NSiMe₃)₂}]

[0067] To a suspension of TiCl₄(THF)₂ (0.12 g, 0.35 mmol) in diethyl ether (10 ml) the dilithium salt Li₂C(Ph₂P═NSiMe₃)₂ (0.20 g, 0.35 mmol) was added with stirring at room temperature. The mixture was stirred at room temperature for 2 days. Diethyl ether was removed and the resultant yellow solid product was extracted with 8 mL of toluene and filtered to remove LiCl. The toluene solution was then concentrated to half and added 5 mL of hexane. Yellow crystalline compound obtained at room temperature over a period of one day. The product was filtered and dried in vacuum. Yield (0.13 g, 54.1%). IR data (Nujol Mull): 1437m, 1296m, 1250m, 1112s, 1079m, 1062s, 1026w, 999w, 843s, 782m, 745w, 721m, 714m, 695m, 652m, 636w, 610m, 569w, 523s. ¹H NMR (C₆D₆): δ7.62 (m, phenyl), 7.00 (m, phenyl), 6.92 (m, phenyl), 6.93 (m, phenyl), 0.37 (s, 18 H, CH₃Si methyl). ¹³C {¹H} NMR (C₆D₆): δ191.0 (t, ¹J_(PC)=145 Hz, 1 C, PCP carbene), 132.7 (m, 4 C, ipso phenyl), 132.0 (t, ²J_(PC)=6.2Hz, 8 C, ortho phenyl), 131.6 (s, 4 C, para phenyl), 128.6 (t, ³J_(PC)=6.2 Hz, 8 C, meta phenyl), 3.1 (s, 6 C, CH₃Si). ³¹P{¹H} NMR (C₆D₆): δ12.61 (2 P).

[0068] Analysis calculated for C₃₁H₃₈Cl₂N₂P₂Si₂Ti: C, 55.11; H, 5.67; N, 4.15. Found: C, 53.93; H, 5.45; N, 3.84.

[0069] Preparation of [Sm{C(Ph₂P═NSiMe₃)₂—(NCy₂)(THF)]

[0070] To a toluene (4 mL) solution of [Sm(NCy₂)₃(THF)] (0.205 g, 0.268 mmol), H₂C(Ph₂P═NSiMe₃)₂ (0.15 g, 0.268 mmol) was added with stirring at room temperature. The reaction mixture was stirred at room temperature for a day and then refluxed for 30 minutes. Cooling the solution to room temperature and allowing the flask to stand for two days gave bright yellow crystals which were isolated by filtration. The crystals were dried under vacuum. Yield: 0.14 g, 54.4%. IR data (Nujol Mull): 1435s, 1341w, 1243s, 1177w, 1146m, 1107s, 1086s, 1065s, 1026s, 948m, 917w, 886m, 834s, 763s, 749s, 729m, 713s, 699s, 678w, 659m, 648m, 608s, 548s, 521s, 511s, 480s. ³¹P{¹H} NMR (C₆D₆): δ43.3 (br.s). Analysis calculated for C₄₇H₆₈N₃OP₂Si₂Sm: C, 58.83; H, 7.14; N, 4.38. Found: C, 59.39; H, 7.25; N, 4.40. 

What is claimed is:
 1. A complex having the formula:

wherein M is a metal atom selected from the group consisting of transition metal, lanthanides and group 11 and 12 post transition metals; R¹, R², R³ and R⁴ are independently selected from the group consisting of a hydrogen atom, a saturated or unsaturated straight chained, branched or cyclic hydrocarbyl radical which is unsubstituted or substituted by one or more substituents selected from the group consisting of a halogen atom and C₁₋₆ alkyl radical; R⁷ and R⁸ are independently selected from the group consisting of a hydrogen atom, a halogen atom, an amide —NR¹R², imide ═NR¹, a alkoxide or aryl oxide group —OR¹, and an —OSi(R¹)₃ group where R¹ and R² are defined above, a saturated or unsaturated straight chained, branched or cyclic hydrocarbyl radical which are unsubstituted or substituted by a halogen atom or a C₁₋₆ alkyl radical or a Lewis base (neutral coordinating ligands); and each R⁵ is independently selected from the group consisting of radicals selected from the group consisting of saturated and unsaturated straight chained, branched and cyclic hydrocarbyl radicals; radicals of the formula Si(R⁶)₃ wherein each R⁶ is independently selected from the group consisting of saturated or unsaturated straight chained, branched or cyclic hydrocarbyl radicals; and radicals of the formula III:

wherein R⁹, R¹⁰, R¹¹ and R¹² are independently selected from the group consisting of a hydrogen atom, a fluorine atom, a NO₂ radical, a C₁₋₆ alkyl radical, and a C₈₋₁₂ aryl radical and E is an endocyclic nitrogen atom or a C—CN group.
 2. A complex dilithium salt of the formula II:

wherein R¹, R², R³ and R⁴ are independently selected from the group consisting of a hydrogen atom, a saturated and unsaturated straight chained, branched and cyclic hydrocarbyl radical which are unsubstituted or substituted by one or more substituents selected from the group consisting of a halogen atom and a C₁₋₆ radical; and each R⁵ is independently selected from the group consisting of radicals selected from the group consisting of saturated and unsaturated straight chained, branched and cyclic hydrocarbyl radicals; radicals of the formula Si(R⁶)₃ wherein each R⁶ is independently selected from the group consisting of saturated or unsaturated straight chained, branched or cyclic hydrocarbyl radicals, radicals of the formula III:

wherein R⁹, R¹⁰, R¹¹ and R¹² are independently selected from the group consisting of a hydrogen atom, a fluorine atom, a NO₂ radical, a C₁₋₆ alkyl radical, and a C₈₋₁₂ aryl radical and E is an endocyclic nitrogen atom or a C—CN group.
 3. The complex according to claim 1, wherein R¹, R², R³ and R⁴ are selected from the group consisting of C₁₋₁₀ straight chained, branched or cyclic alkyl radicals which are unsubstituted or substituted by up to three substituents selected from the group consisting of a chlorine atom, a fluorine atom, C₁₋₄ alkyl radicals, and C₅₋₁₄ aromatic radicals which are unsubstituted or further substituted by up to n−1, wherein n is the number of carbon atoms in the aromatic radical substituents selected from the group consisting of a fluorine atom, a chlorine atom and a C₁₋₆ alkyl radical or an amido radical which is unsubstituted or substituted by up to two C₁₋₆ alkyl radicals.
 4. The complex according to claim 3, wherein R⁷ and R⁸ are selected from the group consisting of a chlorine atom, a fluorine atom, a C₁₋₁₀ straight chained, branched or cyclic alkyl radicals which are unsubstituted or substituted by up to three substituents selected from the group consisting of a chlorine atom, a fluorine atom, C₁₋₄ alkyl radicals and C₅₋₁₄ aromatic radicals which are unsubstituted or further substituted by up to n−1, wherein n is the number of carbon atoms in the aromatic radical substituents selected from the group consisting of a fluorine atom, a chlorine atom, C₁₋₆ alkyl radicals or an amido radical which is unsubstituted or substituted by up to two C₁₋₆ alkyl radicals or a Lewis base (neutral coordinating ligands) selected from the group consisting of ethers, tertiary amines, tertiary phosphines and cyclic amines.
 5. The complex according to claim 4, wherein R¹, R², R³ and R⁴ are selected from the group consisting of a hydrogen atom, a fluorine atom, a chlorine atom, a methyl radical, an ethyl radical, a propyl radical, a butyl radical, a tertiary butyl radical and a phenyl radical.
 6. The complex according to claim 5, wherein R⁵ is the radical —Si(R⁶)₃ and R⁶ is selected from the group consisting of C₁₋₆ alkyl radicals.
 7. The complex according to claim 6, wherein at least one of R⁷ and R⁸ is a C₅₋₁₃ ligand containing a 5 membered carbon ring having delocalized bonding within the ring and bound to the metal atom through covalent η⁵ bonds.
 8. The complex according to claim 7, wherein at least one of R⁷ and R⁸ is selected from the group consisting of cyclopentadienyl, indenyl and fluorenyl which are unsubstituted or up to fully substituted by a member selected from the group consisting of a chlorine atom, a fluorine atom, and an amido radical which is unsubstituted or substituted by up to two C₁₋₄ alkyl radicals.
 9. The complex according to claim 5, wherein R⁵ is a radical of the formula III:

wherein R⁹, R¹⁰, R¹¹ and R¹² are independently selected from the group consisting of a hydrogen atom, a fluorine atom, a NO₂ radical, a C₁₋₆ alkyl radical, and a C₈₋₁₂ aryl radical and E is an endocyclic nitrogen atom or a C—CN group.
 10. The complex according to claim 9, wherein at least one of R⁷ and R⁸ is a C₅₋₁₃ ligand containing a 5 membered carbon ring having delocalized bonding within the ring and bound to the metal atom through covalent η⁵ bonds.
 11. The complex according to claim 10, wherein at least one of R ⁷ and R⁸ is selected from the group consisting of cyclopentadienyl, indenyl and fluorenyl which are unsubstituted or up to fully substituted by a member selected from the group consisting of a chlorine atom, a fluorine atom, and an amido radical which is unsubstituted or substituted by up to two C₁₋₄ alkyl radicals.
 12. The complex according to claim 11, wherein E is an endocyclic nitrogen atom.
 13. The complex according to claim 11, wherein E is a C—CN group.
 14. The complex according to claim 11, wherein R⁵ is a 4-cyanotetrafluorophenyl radical.
 15. The complex according to claim 5, wherein R⁵ is selected from the group consisting of a C₁₋₈ straight or branched alkyl radical or a C₆₋₁₂ cyclic aliphatic or aromatic radical.
 16. The complex according to claim 15, wherein at least one of R⁷ and R⁸ is a C₅₋₁₃ ligand containing a 5 membered carbon ring having delocalized bonding within the ring and bound to the metal atom through covalent η⁵ bonds.
 17. The complex according to claim 16, wherein at least one of R⁷ and R⁸ is selected from the group consisting of cyclopentadienyl, indenyl and fluorenyl which are unsubstituted or up to fully substituted by a member selected from the group consisting of a chlorine atom, a fluorine atom, and an amido radical which is unsubstituted or substituted by up to two C₁₋₄ alkyl radicals.
 18. The complex according to claim 17, wherein R⁵ is selected from the group consisting of methyl, ethyl, butyl, phenyl and adamantyl radicals.
 19. The complex according to claim 2, wherein R¹, R², R³ and R⁴ are selected from the group consisting of C₁₋₁₀ straight chained, branched or cyclic alkyl radicals which are unsubstituted or substituted by up to three substituents selected from the group consisting of a chlorine atom, a fluorine atom, C₁₋₄ alkyl radicals, and C₅₋₁₄ aromatic radicals which are unsubstituted or further substituted by up to n−1, wherein n is the number of carbon atoms in the aromatic radical substituents selected from the group consisting of a fluorine atom, a chlorine atom and a C₁₋₆ alkyl radical or an amido radical which is unsubstituted or substituted by up to two C₁₋₆ alkyl radicals.
 20. The complex according to claim 19, wherein R⁷ and R⁸ are selected from the group consisting of a chlorine atom, a fluorine atom, a C₁₋₁₀ straight chained, branched or cyclic alkyl radicals which are unsubstituted or substituted by up to three substituents selected from the group consisting of a chlorine atom, a fluorine atom, C₁₋₄ alkyl radicals and C₅₋₁₄ aromatic radicals which are unsubstituted or further substituted by up to n−1, wherein n is the number of carbon atoms in the aromatic radical substituents selected from the group consisting of a fluorine atom, a chlorine atom, C₁₋₆ alkyl radicals or an amido radical which is unsubstituted or substituted by up to two C₁₋₆ alkyl radicals.
 21. The complex according to claim 20, wherein R¹, R², R³ and R⁴ are selected from the group consisting of a hydrogen atom, a fluorine atom, a chlorine atom, a methyl radical, an ethyl radical, a propyl radical, a butyl radical, a tertiary butyl radical and a phenyl radical.
 22. The complex according to claim 21, wherein R⁵ is the radical —Si(R⁶)₃ and R⁶ is selected from the group consisting of C₁₋₆ alkyl radicals.
 23. The complex according to claim 21, wherein R⁵ is a radical of the formula III:

wherein R⁹, R¹⁰, R¹¹ and R¹² are independently selected from the group consisting of a hydrogen atom, a fluorine atom, a NO₂ radical, a C₁₋₆ alkyl radical, and a C₈₋₁₂ aryl radical and E is an endocyclic nitrogen atom or a C—CN group.
 24. The complex according to claim 23, wherein E is an endocyclic nitrogen atom.
 25. The complex according to claim 24, wherein E is a C—CN group.
 26. The complex according to claim 25, wherein R⁵ is a 4-cyanotetrafluorophenyl radical.
 27. The complex according to claim 21, wherein R⁵ is selected from the group consisting of a C₁₋₈ straight or branched alkyl radical and a C₆₋₁₂ cyclic aliphatic or aromatic radical.
 28. The complex according to claim 27, wherein R⁵ is selected from the group consisting of methyl, ethyl, butyl, phenyl and adamantyl radicals.
 29. A process for preparing a complex as defined in claim 1, comprising either: (A) reacting a compound of the formula I:

 wherein R¹, R², R³, R⁴ and R⁵ are as defined in claim 1, with a compound of the formula M(X)_(s)(Y)_(t)(L)_(n) wherein M is as defined in claim 1, X and Y are independently selected from a group consisting of an alkyl, preferably having from 1 to 10 carbon atoms which is unsubstituted or substituted by a C₁₋₄ alkyl radical or a C₆₋₁₀ aryl radical, a silylated amido or imido complex —N(Si(R⁶)₃)₂ or ═N(Si(R⁶) respectivel where R⁶ is as defined in claim 1 or imido ═NR radicals where R is a C₁₋₁₀ alkyl or a C₆₋₁₀ aryl radical, Y is selected from the group consisting of a halogen atom, alkoxy radicals having from 1 to 10 carbon atoms and aryloxy radicals having from 6 to 10 carbon atoms, and the sum of s and t equal the valence of the transition metal M and provided that at least two of the X and Y groups can be eliminated from the compound, L is or a Lewis base and n is from 0 to 3, in a C₅₋₁₂ hydrocarbyl solvent or a C₂₋₁₀ ether solvent at a temperature from 20° C. to 150° C.; or (B) reacting a compound of the formula II:

 wherein R¹, R², R³, R⁴ and R⁵ are as defined above, with a compound of the formula M(X)_(s)(Y)_(t)(L)_(n) wherein M, X, Y, L, s, t and n are as defined above in a C₅₋₁₂ hydrocarbyl solvent or a C₂₋₁₀ ether solvent at a temperature from 20° C. to 150° C.
 30. The process of claim 29, wherein a compound of formula I is reacted.
 31. The process according to claim 30, wherein R¹, R², R³ and R⁴ are selected from the group consisting of C₁₋₁₀ straight chained, branched or cyclic alkyl radicals which are unsubstituted or substituted by up to three substituents selected from the group consisting of a chlorine atom, a fluorine atom, C₁₋₄ alkyl radicals, and C₅₋₁₄ aromatic radicals which are unsubstituted or further substituted by up to n−1, wherein n is the number of carbon atoms in the aromatic radical substituents selected from the group consisting of a fluorine atom, a chlorine atom, C₁₋₆ alkyl radicals, and an amido radical which is unsubstituted or substituted by up to two C₁₋₆ alkyl radicals.
 32. The process according to claim 31, wherein the solvent is selected from the group consisting of pentene, hexane, heptene, octane, cyclohexane, methyl cyclohexane, benzene, toluene, xylene, hydrogenated naphtha, diethyl ether and diglyme.
 33. The process according to claim 32, wherein R⁵ is the radical —Si(R⁶)₃ and R⁶ is selected from the group consisting of C₁₋₆ alkyl radicals.
 34. The process according to claim 33, wherein R⁵ is a radical of the formula III:

wherein R⁹, R¹⁰, R¹¹ and R¹² are independently selected from the group consisting of a hydrogen atom, a fluorine atom, a NO₂ radical, a C₁₋₆ alkyl radical, and a C₈₋₁₂ aryl radical and E is an endocyclic nitrogen atom or a C—CN group.
 35. The process according to claim 34, wherein E is an endocyclic nitrogen atom.
 36. The process according to claim 34, wherein E is a C—CN group.
 37. The complex according to claim 34, wherein R⁵ is a 4-cyanotetrafluorophenyl radical.
 38. The process according to claim 32, wherein R⁵ is selected from the group consisting of a C₁₋₈ straight or branched alkyl radical and a C₆₋₁₂ cyclic aliphatic or aromatic radical.
 39. The process according to claim 34, wherein R⁵ is selected from the group consisting of methyl, ethyl, butyl, phenyl and adamantyl radicals.
 40. The process according to claim 29, wherein a compound of formula II is reacted.
 41. The process according to claim 40, wherein R¹, R², R³ and R⁴ are selected from the group consisting of C₁₋₁₀ straight chained, branched or cyclic alkyl radicals which are unsubstituted or substituted by up to three substituents selected from the group consisting of a chlorine atom, a fluorine atom, C₁₋₄ alkyl radicals, and C₅₋₁₄ aromatic radicals which are unsubstituted or further substituted by up to n−1, wherein n is the number of carbon atoms in the aromatic radical substituents selected from the group consisting of a fluorine atom, a chlorine atom, C₁₋₆ alkyl radicals, and an amido radical which is unsubstituted or substituted by up to two C₁₋₆ alkyl radicals.
 42. The process according to claim 41, wherein the solvent is selected from the group consisting of pentene, hexane, heptene, octane, cyclohexane, methyl cyclohexane, benzene, toluene, xylene, hydrogenated naphtha, diethyl ether and diglyme.
 43. The process according to claim 42, wherein R⁵ is the radical —Si(R⁶)₃ and R⁶ is selected from the group consisting of C₁₋₆ alkyl radicals.
 44. The process according to claim 42, wherein R⁵ is a radical of the formula III:

wherein R⁹, R¹⁰, R¹¹ and R¹² are independently selected from the group consisting of a hydrogen atom, a fluorine atom, a NO₂ radical, a C₁₋₆ alkyl radical, and a C₈₋₁₂ aryl radical and E is an endocyclic nitrogen atom or a C—CN group.
 45. The process according to claim 44, wherein E is an endocyclic nitrogen atom.
 46. The process according to claim 44, wherein E is a C—CN group.
 47. The complex according to claim 44, wherein R⁵ is a 4-cyanotetrafluorophenyl radical.
 48. The process according to claim 42, wherein R⁵ is selected from the group consisting of a C₁₋₈ straight or branched alkyl radical and a C₆₋₁₂ cyclic aliphatic or aromatic radical.
 49. The process according to claim 48, wherein R⁵ is selected from the group consisting of methyl, ethyl, butyl, phenyl and adamantyl radicals.
 50. A process comprising reacting a complex of the formula:

wherein R¹, R², R³, R⁴ and R⁵ are as defined in claim 1, and at least one R⁷ and R⁸ are halogens and the other may be a Lewis base as defined in claim 1 with a Grignard reagent or an alkylating or alkoxylating agent.
 51. The process according to claim 50, wherein Grignard reagent has formula RMgX wherein R is a C₁₋₁₀ branched or straight chained alkyl or aromatic radical, and X is a halogen atom to fully or partially alkylate the complex.
 52. The process according to claim 50, wherein the alkylating agent is LiR wherein R is a C₁₋₁₀ branched or straight chain alkyl or aromatic radical to fully or partially alkylate the complex.
 53. The process according to claim 50, wherein the reagent is M²OR wherein M² is an alkali metal and R is a C₁₋₁₀ branched or straight chained alkyl or aromatic radical to fully or partially alkoxylate the complex. 